ViziLiteÂ® Plus with TBlueÂ® is the leading oral cancer screening system that was developed to help oral healthcare professionals identify, evaluate, monitor and mark abnormal oral lesions suspicious for pathology including precancerous cells and cancer that may be difficult to see during a regular visual exam.
ViziLiteÂ® Plus with TBlueÂ® is an easy-to-use system that takes just 90 seconds to perform. It incorporates seamlessly into your existing oral cancer screening examinations. Below are the simple-to-use steps when conducting a ViziLiteÂ® Plus with TBlueÂ® oral cancer screening exam.
How ViziLiteÂ® Plus with TBlueÂ® Works
When cells mutate from normal to becoming cancerous they go through many changes. One change that occurs within the cell is the replication of nuclear DNA at an accelerated rate. The DNA takes up a greater percentage of the total cell volume as shown in the illustration below. The ratio between the nucleus and the cytoplasm can increase until the nucleus takes up nearly 100% of the cell volume.
With ViziLiteÂ® Plus with TBlueÂ®, oral healthcare professionals now have a diagnostic aid that helps them identify, evaluate, monitor and mark abnormal oral lesions that may be going through these dysplastic changes. The pre-rinse solution in ViziLiteÂ® Plus with TBlueÂ® slightly desiccates the cells to make the nuclei more prominent, and, therefore, more visible. The low intensity light from the handheld light source is reflected off of these abnormal cells down to the basement membrane where the nuclei have been rendered more prominent, and appear to “glow” making abnormal cells easier to see.